Search for Roche Holding AG and
  1. July 16, 2014

    Eli Lilly joins forces with UK biotech to develop cancer drugs

    Eli Lilly has entered the race to develop a new generation of oncology drugs, which harness the immune system to kill cancer...

  2. July 2, 2014

    Roche to buy US cancer drug group Seragon

    Roche has agreed to buy Seragon Pharmaceuticals, a privately owned US biotech company, for up to $1.7bn, in a deal that...

  1. June 30, 2014

    Roche rebuts criticism of Tamiflu stockpiling

    Roche has hit back against what it termed a “seriously flawed” study that said the UK government had wasted almost £500m...

  2. June 2, 2014

    Roche to buy Genia of US for up to $350m

    Roche is to buy the US gene-sequencing company Genia in a deal that could cost up to $350m, as the Swiss pharmaceuticals...

  3. May 30, 2014

    Hopes for cancer cures offer comfort for battered pharma

    It is the Holy Grail of medical science. Ever since Hippocrates, the Greek physician, first described the disease more than...

  4. May 29, 2014

    Italian health ministry to seek €1.2bn from Roche and Novartis

    Italy’s health ministry said that it plans to seek damages of €1.2bn from Roche and Novartis after the Italian antitrust...

  5. May 23, 2014

    Chinese officials deny Roche visit was bribery-related

    Local government officials in the eastern Chinese city of Hangzhou on Friday denied that a visit this week to the local...

  6. April 15, 2014

    Roche drug boosts to revenue counteracted by currency’s strength

    Roche’s revenues fell 1 per cent in the first quarter as the strength of the Swiss franc weighed on the pharma group, even...

  7. April 11, 2014

    Big pharma: Storehouse of trouble

    Mark Lanier is no ordinary trial lawyer. His success has been such that he lives on a 25-acre estate near Houston and hosts...

  8. April 10, 2014

    French probe alleged drug collusion

    France’s competition authority is investigating Roche and Novartis over alleged collusion to protect one of their...

  9. March 26, 2014

    Kim Lim: Carvings, Roche Court, Wiltshire, UK – review

    Set amid lush Wiltshire countryside, the New Art Centre’s luminous gallery at Roche Court is an ideal setting for Kim Lim....

  10. March 13, 2014

    Lufthansa revives dividend as restructuring efforts take effect

    Lufthansa reinstated its dividend as the restructuring of its European network began to bear fruit; the German airline also...

  11. March 4, 2014

    Roche chairman fears for R&D amid squeeze on investment

    Europe risks losing investment in research and development because of the reluctance of cash-strapped governments to pay for...

  12. February 7, 2014

    Roche wins battle against India sales of generic cancer drug

    Two generic pharmaceutical companies have been ordered to stop selling their version of a Roche breast cancer treatment in...

  13. January 30, 2014

    Roche to lead way on corporate governance crackdown

    Roche will become one of the first big Swiss companies to implement tough new corporate governance rules designed to remove...

  14. January 29, 2014

    Novartis considers future of $14bn Roche stake

    Novartis’s $14bn stake in its local rival Roche is one of the assets it is scrutinising as part of a broader review of its...

  15. January 27, 2014

    Hepatitis C: Treated – at a price

    Gemma Peppe lived with hepatitis C for two decades before she – and the teenage son she inadvertently infected at birth –...

  16. January 8, 2014

    AstraZeneca strikes deal with UK’s Immunocore

    AstraZeneca has struck a deal with a fast-growing UK biotech company to develop treatments that use the body’s immune system...

  17. October 17, 2013

    Roche / Novartis: combination therapy

    Winter might be descending on the Alps, but spring is in the air in Basel. The Swiss city, home to Roche and Novartis, has...

  18. September 30, 2013

    Roche chief Severin Schwan open to co-operation with Novartis

    Roche’s chief executive has signalled openness to renewed co-operation with counterparts at his Swiss rival Novartis, in a...

  19. September 30, 2013

    Europe belt tightening will hit pharma, warns Roche chief

    Europe risks squandering its leading position in the global pharmaceuticals industry because of the “short-term” and...

  20. September 27, 2013

    QI is an option when good buys are scarce

    Even the world’s greatest stockpicker thinks there’s not much good value to be had. “We’re having a hard time finding things...

  21. September 16, 2013

    Roche poaches Lufthansa chief executive Christoph Franz

    Christoph Franz is to step down as chief executive of Lufthansa midway through the German airline’s restructuring programme...

  22. September 4, 2013

    Why are good managers such a rare species?

    Becoming a better boss: Why good management is so difficult, by Julian Birkinshaw, Wiley, RRP£18.99 How likely is it that...

  23. September 3, 2013

    BioMérieux buys privately held BioFire for $450m

    BioMérieux, the quoted French diagnostics company, is to pay $450m to buy a US rival in a deal designed to reinforce and...

  24. August 16, 2013

    Roche drops patent for Herceptin in India

    Roche, the Swiss drugmaker, has decided to relinquish its patent on the breast cancer drug Herceptin in the Indian market,...

  25. August 12, 2013

    Pharmaceuticals: Back to the lab

    He has promised no big shift in strategy or focus, spurned big acquisitions and suffered a series of research setbacks. Yet...

  26. August 8, 2013

    Surgery needed to keep Novartis in shape

    The strength of Novartis is that it does what a big drug company should do: it makes original drugs that cure or ease the...

  27. July 25, 2013

    Roche chief Severin Schwan plays down risk of graft scandal in China

    Roche’s chief executive played down the dangers of the corruption scandal that has embroiled GlaxoSmithKline in China for...

  28. July 15, 2013

    Wall St rises slightly after Citigroup earnings

    US stocks edged up on Monday after hitting record highs in the previous session, as better than expected earnings from...

  29. July 15, 2013

    AstraZeneca chief financial officer set to move to BG Group

    Simon Lowth, chief financial officer at AstraZeneca, is set to join oil and gas company BG Group a year after he missed out...

  30. July 10, 2013

    Roche to end trials of diabetes drug due to side-effect concerns

    Roche is to terminate trials of a key experimental diabetes drug due to concerns about its side-effects, in a new setback...

  31. June 27, 2013

    Drugs groups face credit rating threat as population ages

    Credit ratings of the world’s largest pharmaceutical groups are set to suffer as governments try to control the cost of...

  32. May 28, 2013

    Lifetime achievement: Light dawned for Martin Schadt as crystals dimmed

    The interview is coming to an end when Martin Schadt notices my Dictaphone. “How long does it last before you change the...

  33. May 22, 2013

    Metro rises after broker gets positive

    Metro was in high demand after the German retailer received a vote of confidence from Morgan Stanley analysts for the first...

  34. May 22, 2013

    US doctors paid $1bn by top drug companies

    A dozen leading drug companies paid US doctors a total of more than $1bn last year, according to fresh data revealing the...

  35. May 21, 2013

    NHS wasted £74m on Tamiflu, says watchdog

    The health service needs to improve its management of flu pandemic medicines after £74m was squandered because of poor...

  36. May 15, 2013

    India: Patents and precedents

    Meena, a 45-year-old New Delhi widow with a 10-year-old son, was diagnosed with potentially fatal blood cancer in 2010. To...

  37. May 2, 2013

    Contenders for top Shell job likely to come from inside group

    Royal Dutch Shell has said it will be looking at both external and internal candidates to replace Peter Voser: but most...

  38. April 30, 2013

    Court stops EU regulator releasing drug trial data

    The European Medicines Agency has been blocked from releasing clinical trial data generated by AbbVie and InterMune, under a...

Search for Roche Holding AG and